康缘药业董事江锁成、副总经理鲜飞鹏辞任

Core Viewpoint - Kangyuan Pharmaceutical (600557) announced changes in its executive team, including the resignation of Jiang Suocheng as CFO and board member, and the appointment of Li Qing as the new CFO [1] Group 1: Executive Changes - Jiang Suocheng resigned from his positions as a board member, strategic committee member, and CFO due to work adjustments, but will continue to work at the company [1] - Xian Feipeng resigned from his position as Deputy General Manager for personal reasons and will not hold any positions in the company or its subsidiaries after his resignation [1] - The company held a board meeting to appoint Li Qing as the new CFO, effective from the date of board approval until the end of the current board's term [1]